AOD-9604

What it is

AOD-9604 is a synthetic fragment corresponding to residues 176-191 of human growth hormone, with a tyrosine added at the N-terminus for stability. Human growth hormone is 191 amino acids; this is the final sixteen of them plus one.

The reason a fragment that short attracted attention is a specific structure-function claim: the C-terminal region of growth hormone was reported to carry lipolytic activity separable from the hormone's growth-promoting and glucose-affecting activity, which sits elsewhere in the molecule. If true, the fragment would allow one activity to be studied without the others.

What the preclinical literature actually shows

In vitro and in rodent adipose-tissue models, the fragment has been reported to affect lipolytic and lipogenic signalling without the IGF-1 elevation that characterises intact growth hormone. That separation — an effect on fat metabolism without engaging the growth axis — is the entire research interest in the compound.

It is also where the evidence gets thinner than the popular summaries suggest. The mechanism is not well established; the fragment does not appear to act through the growth-hormone receptor in the way the intact hormone does, and proposals involving beta-3 adrenergic signalling have not been settled. Results across models have not been uniformly reproducible.

This is worth stating plainly because AOD-9604 is frequently described online with a confidence the literature does not support. In a research context the honest position is that it is an interesting structure-function hypothesis with an incomplete mechanistic account.

Why fragment research is methodologically useful

Independent of whether this particular fragment holds up, the approach it represents is a standard one. Taking a large multifunctional protein apart and asking which region carries which activity is how structure-function relationships get mapped, and growth hormone — with its distinct growth-promoting, metabolic and lactogenic activities — is an obvious candidate for that treatment.

Fragments also raise a purity question sharply. A sixteen-residue synthetic peptide is short enough that deletion sequences and truncation by-products are chemically similar to the target, which makes them harder to resolve and makes the HPLC chromatogram more informative than the summary percentage. For any short fragment, look at the trace, not only the number.

How to read a structure-function claim

The claim behind this fragment has a specific shape: a large protein carries several activities, those activities map to distinct regions, and isolating a region isolates an activity. Where it holds it is powerful. It often does not hold, because activity frequently depends on the folded context the fragment was removed from.

The questions worth asking of any fragment claim are the same each time. Does the fragment act through the parent protein’s receptor, through something else, or is the mechanism simply unassigned? Has the separation of activities been shown directly, or only inferred from the absence of one of them? And has anyone outside the originating group reproduced it?

For AOD-9604 the honest answers are: mechanism unassigned, separation largely inferred, replication limited. That is a legitimate research position — it is just not an established one, and the difference is what most summaries of this compound erase.

Short synthetic peptides and their impurity profile

Solid-phase synthesis builds a peptide one residue at a time, and every coupling step is slightly less than perfect. The characteristic by-products are deletion sequences missing a single residue — chemically almost identical to the target, and eluting very close to it.

On a chromatogram those show up as shoulders on the main peak, or a cluster of small peaks immediately beside it, rather than as cleanly separated contaminants. A purity percentage integrated from a method that does not resolve them will read high while the material is materially heterogeneous.

This is the concrete reason to look at the trace and not only the number, and it matters more for short peptides than long ones, because the relative difference between an n and an n-minus-one species is smaller.

Not stocked here

We do not sell AOD-9604. This entry exists because it is a commonly asked-about compound and the accurate version — a structure-function hypothesis with an unsettled mechanism — is not the version usually available.

For laboratory research use only. All findings described are preclinical.